- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT03499535
Impact of Smoking Information on Concerns About Radon
17 de abril de 2019 actualizado por: Paul Windschitl
Despite a push for tailored messages, health communications are often aimed at, and viewed by, people with varying levels of risk.
This project examined-in the context of radon risk messages-whether information relevant to high-risk individuals can have an unintended influence on lower-risk individuals.
Specifically, the investigators assessed whether information about lung-cancer risk from smoking reduced concerns about lung-cancer risk from radon among nonsmokers.
The investigators hypothesized that non-smokers who read a message that included smoking-relevant information would express less concern about the effects of radon exposure and less interest in testing their home compared to those who read a version in which smoking-relevant information was excluded.
Two studies were conducted.
Although the investigators did not exclude smokers, the focus was on participants self-identifying as nonsmokers (including never smokers and former smokers).
Descripción general del estudio
Estado
Terminado
Condiciones
Descripción detallada
Despite a push for tailored messages, health communications are often aimed at, and viewed by, people with varying levels of risk.
This project examined-in the context of radon risk messages-whether information relevant to high-risk individuals can have an unintended influence on lower-risk individuals.
Specifically, the investigators assessed whether information about lung-cancer risk from smoking reduced concerns about lung-cancer risk from radon among nonsmokers.
The investigators hypothesized that non-smokers who read a message that included smoking-relevant information would express less concern about the effects of radon exposure and less interest in testing their home compared to those who read a version in which smoking-relevant information was excluded.
Two studies were conducted.
Although the investigators did not exclude smokers, the focus was on participants self-identifying as nonsmokers (including never smokers and former smokers).
Participants in both studies were recruited through Amazon's Mechanical Turk (MTurk).
Participants viewed radon messages that varied in the information they communicated about smoking's effect on lung cancer.
In Study 1, smoking information was included or excluded from messages assembled from existing radon pamphlets.
In Study 2, versions of a new radon message either excluded smoking information, described smoking as a major cause of lung cancer, or also described smoking's synergistic effect with radon on lung cancer risk.
After viewing a radon health message, participants completed a variety of measures.
Primary measures assessed respondents' anticipated sense of concern and related reactions if they learned that they/their home had been exposed to elevated levels of radon.
Other key measures included questions about participants' interest and intention to test their home for radon.
Tipo de estudio
Intervencionista
Inscripción (Actual)
1390
Fase
- No aplica
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
18 años y mayores (Adulto, Adulto Mayor)
Acepta Voluntarios Saludables
Sí
Géneros elegibles para el estudio
Todos
Descripción
Inclusion Criteria:
- Live within the US
- Have an Amazon Mechanical Turk account (website where online study was posted)
Exclusion Criteria:
- None
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Prevención
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación factorial
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Comparador activo: Study 1: Radon&Smoking Synergistic/EPA
Participants viewed radon and smoking risk information taken from the EPA's pamphlet on the dangers of radon gas exposure.
|
Participants viewed health information detailing the risks of developing lung cancer from exposure to radon gas, smoking, and their synergistic effects.
This intervention represents the type of information most commonly presented in radon risk communications.
Health information modeled after the Environmental Protection Agency's (EPA) pamphlet on radon risk.
|
|
Comparador activo: Study 1: Radon&Smoking Synergistic/Idaho
Participants viewed radon and smoking risk information taken from Idaho's Department of Health and Human Welfare's pamphlet on the dangers of radon gas exposure.
|
Participants viewed health information detailing the risks of developing lung cancer from exposure to radon gas, smoking, and their synergistic effects.
This intervention represents the type of information most commonly presented in radon risk communications.
Health information modeled after the Idaho Department of Health and Human Welfare's pamphlet on radon risk.
|
|
Experimental: Study 1: Radon Only / EPA
Participants viewed only radon risk information taken from the EPA's pamphlet on the dangers of radon gas exposure.
|
Health information modeled after the Environmental Protection Agency's (EPA) pamphlet on radon risk.
Participants viewed health information detailing the risks of developing lung cancer from radon exposure.
No information about the risks for developing lung cancer associated with smoking or its synergistic effect with radon exposure are included.
|
|
Experimental: Study 1: Radon Only / Idaho
Participants viewed only radon risk information taken from Idaho's Department of Health and Human Welfare's pamphlet on the dangers of radon gas exposure.
|
Health information modeled after the Idaho Department of Health and Human Welfare's pamphlet on radon risk.
Participants viewed health information detailing the risks of developing lung cancer from radon exposure.
No information about the risks for developing lung cancer associated with smoking or its synergistic effect with radon exposure are included.
|
|
Experimental: Study 2: Radon Only
Participants viewed a radon-only message that focused only on the effect of radon on lung-cancer risk.
|
Participants viewed health information detailing the risks of developing lung cancer from radon exposure.
No information about the risks for developing lung cancer associated with smoking or its synergistic effect with radon exposure are included.
|
|
Otro: Study 2: Radon and Smoking Isolated
Participants viewed a radon-and-smoking-isolated message that covered the individual effects of radon and of smoking on lung cancer, but without mentioning their synergistic effect.
|
Participants viewed health information detailing the risks of developing lung cancer from radon exposure and smoking.
No information describing the synergistic effects of smoking and radon exposure on lung cancer risk are included.
|
|
Comparador activo: Study 2: Radon & Smoking Synergistic
Participants viewed a radon-and-smoking-synergistic message that covered the individual effects of radon and of smoking but that also included information about their synergistic effect.
|
Participants viewed health information detailing the risks of developing lung cancer from exposure to radon gas, smoking, and their synergistic effects.
This intervention represents the type of information most commonly presented in radon risk communications.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Conditional Concern Composite
Periodo de tiempo: Immediately post-intervention (approx. 1 minute)
|
Composite formed from 4 conditional questions assessing concern, perceived impact on risk and comparative risk, and threat--if exposed to radon
|
Immediately post-intervention (approx. 1 minute)
|
|
Interest in Testing Composite
Periodo de tiempo: Immediately post-intervention (approx. 2 minutes)
|
Composite formed from 2 questions assessing importance and intention to test home for radon
|
Immediately post-intervention (approx. 2 minutes)
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Worry Elicited by Health Message
Periodo de tiempo: Immediately post-intervention (approx. 2 minutes)
|
Single question assessing worry elicited by the health communication material
|
Immediately post-intervention (approx. 2 minutes)
|
|
Likelihood Judgments about Lung Cancer
Periodo de tiempo: Immediately post-intervention (approx. 4 minutes)
|
Three items assessing perceived likelihood of developing lung cancer
|
Immediately post-intervention (approx. 4 minutes)
|
|
Elect to Leave Email for Raffle
Periodo de tiempo: Immediately post-intervention (approx. 4 minutes)
|
Participants given option to leave email address in case they won one of the 20 radon kits being raffled (Study 2).
|
Immediately post-intervention (approx. 4 minutes)
|
|
Elect to Read More
Periodo de tiempo: Immediately post-intervention (approx. 4 minutes)
|
Participants given option to be presented with more information at the end of the session about testing for radon (Study 2).
|
Immediately post-intervention (approx. 4 minutes)
|
|
Concern about Loved Ones If Exposed to Radon
Periodo de tiempo: Immediately post-intervention (approx. 4 minutes)
|
Rated how concerned they would be about loved ones if they learned their home had high radon (Study 2)
|
Immediately post-intervention (approx. 4 minutes)
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Patrocinador
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio (Actual)
7 de agosto de 2015
Finalización primaria (Actual)
22 de abril de 2016
Finalización del estudio (Actual)
22 de abril de 2016
Fechas de registro del estudio
Enviado por primera vez
30 de marzo de 2018
Primero enviado que cumplió con los criterios de control de calidad
13 de abril de 2018
Publicado por primera vez (Actual)
17 de abril de 2018
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
19 de abril de 2019
Última actualización enviada que cumplió con los criterios de control de calidad
17 de abril de 2019
Última verificación
1 de abril de 2019
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- 201507727
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
SÍ
Descripción del plan IPD
De-identified data and guide will be made available to other investigators upon request.
Marco de tiempo para compartir IPD
Requested data will be made available upon publication of the project.
Criterios de acceso compartido de IPD
Please contact corresponding author Dr. Paul Windschitl at paul-windschitl@uiowa.edu
Tipo de información de apoyo para compartir IPD
- CÓDIGO_ANALÍTICO
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
No
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
No
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .